The Beauty Health Company Statistics
Total Valuation
SKIN has a market cap or net worth of $122.79 million. The enterprise value is $320.89 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SKIN has 125.25 million shares outstanding. The number of shares has increased by 8.21% in one year.
| Current Share Class | 125.25M |
| Shares Outstanding | 125.25M |
| Shares Change (YoY) | +8.21% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 8.81% |
| Owned by Institutions (%) | 60.06% |
| Float | 80.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.36 |
| Forward PS | 0.39 |
| PB Ratio | 2.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.98 |
| P/OCF Ratio | 7.61 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 20.87 |
Financial Position
The company has a current ratio of 7.00, with a Debt / Equity ratio of 10.97.
| Current Ratio | 7.00 |
| Quick Ratio | 5.86 |
| Debt / Equity | 10.97 |
| Debt / EBITDA | n/a |
| Debt / FCF | 36.95 |
| Interest Coverage | -6.51 |
Financial Efficiency
Return on equity (ROE) is -52.34% and return on invested capital (ROIC) is -5.92%.
| Return on Equity (ROE) | -52.34% |
| Return on Assets (ROA) | -5.25% |
| Return on Invested Capital (ROIC) | -5.92% |
| Return on Capital Employed (ROCE) | -10.98% |
| Revenue Per Employee | $434,713 |
| Profits Per Employee | -$37,839 |
| Employee Count | 769 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.89 |
Taxes
| Income Tax | -452,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.55% in the last 52 weeks. The beta is 0.85, so SKIN's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -69.55% |
| 50-Day Moving Average | 1.29 |
| 200-Day Moving Average | 1.53 |
| Relative Strength Index (RSI) | 41.66 |
| Average Volume (20 Days) | 714,624 |
Short Selling Information
The latest short interest is 8.36 million, so 6.67% of the outstanding shares have been sold short.
| Short Interest | 8.36M |
| Short Previous Month | 8.58M |
| Short % of Shares Out | 6.67% |
| Short % of Float | 10.33% |
| Short Ratio (days to cover) | 10.69 |
Income Statement
In the last 12 months, SKIN had revenue of $334.29 million and -$29.10 million in losses. Loss per share was -$0.36.
| Revenue | 334.29M |
| Gross Profit | 182.30M |
| Operating Income | -67.77M |
| Pretax Income | -80.63M |
| Net Income | -29.10M |
| EBITDA | -34.09M |
| EBIT | -67.77M |
| Loss Per Share | -$0.36 |
Full Income StatementBalance Sheet
The company has $370.06 million in cash and $568.16 million in debt, giving a net cash position of -$198.10 million or -$1.58 per share.
| Cash & Cash Equivalents | 370.06M |
| Total Debt | 568.16M |
| Net Cash | -198.10M |
| Net Cash Per Share | -$1.58 |
| Equity (Book Value) | 51.80M |
| Book Value Per Share | 0.41 |
| Working Capital | 408.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $16.13 million and capital expenditures -$756,000, giving a free cash flow of $15.38 million.
| Operating Cash Flow | 16.13M |
| Capital Expenditures | -756,000 |
| Free Cash Flow | 15.38M |
| FCF Per Share | $0.12 |
Full Cash Flow StatementMargins
Gross margin is 54.53%, with operating and profit margins of -20.27% and -8.70%.
| Gross Margin | 54.53% |
| Operating Margin | -20.27% |
| Pretax Margin | -8.84% |
| Profit Margin | -8.70% |
| EBITDA Margin | -10.20% |
| EBIT Margin | -20.27% |
| FCF Margin | 4.60% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.21% |
| Shareholder Yield | -8.21% |
| Earnings Yield | -23.70% |
| FCF Yield | 12.52% |
Analyst Forecast
The average price target for SKIN is $2.50, which is 155.00% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.50 |
| Price Target Difference | 155.00% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of 0.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.11 |
| Piotroski F-Score | 6 |